Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 377, P. 716 - 734
Published: Dec. 3, 2024
Language: Английский
Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 377, P. 716 - 734
Published: Dec. 3, 2024
Language: Английский
Dalton Transactions, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
We report the anticancer activity of a red light-activable hetero-bimetallic [Fe(iii)–Ru(ii)] complex as next-generation dual-modality PDT tool for photo-activated therapy.
Language: Английский
Citations
1Materials Today Bio, Journal Year: 2024, Volume and Issue: 30, P. 101383 - 101383
Published: Dec. 6, 2024
Language: Английский
Citations
5Acta Biomaterialia, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 1, 2025
Language: Английский
Citations
0International Journal of Biological Macromolecules, Journal Year: 2025, Volume and Issue: unknown, P. 140820 - 140820
Published: Feb. 1, 2025
Language: Английский
Citations
0Chemical Engineering Journal, Journal Year: 2025, Volume and Issue: unknown, P. 160659 - 160659
Published: Feb. 1, 2025
Language: Английский
Citations
0Beilstein Journal of Nanotechnology, Journal Year: 2025, Volume and Issue: 16, P. 195 - 215
Published: Feb. 17, 2025
The human eye, with its remarkable resolution of up to 576 million pixels, grants us the ability perceive world astonishing accuracy. Despite this, over 2 billion people globally suffer from visual impairments or blindness, primarily because limitations current ophthalmic treatment technologies. This underscores an urgent need for more advanced therapeutic approaches effectively halt even reverse progression eye diseases. rapid advancement nanotechnology offers promising pathways development novel therapies. Notably, photothermal nanomaterials, particularly well-suited transparent tissues have emerged as a potential game changer. These materials enable precise and controllable therapy by manipulating distribution thermal field. Moreover, they extend beyond conventional boundaries therapy, achieving unparalleled effects through their diverse composite structures demonstrating enormous in promoting retinal drug delivery photoacoustic imaging. paper provides comprehensive summary structure-activity relationship between properties these nanomaterials innovative mechanisms. We review latest research on nanomaterial-based treatments various Additionally, we discuss challenges future perspectives this field, focus enhancing global health.
Language: Английский
Citations
0Diagnostics, Journal Year: 2025, Volume and Issue: 15(6), P. 659 - 659
Published: March 8, 2025
Background/Objectives: This study explores the micro-structure of celiac ganglia using two-photon microscopy (TPM) to highlight histological features in neurodegenerative conditions. Neurodegenerative diseases like Parkinson’s disease (PD) are linked dysautonomia, impacting autonomic regulation and leading significant gastrointestinal symptoms. Our research compares imaging results from TPM SHG microscopy, visualizing neuronal integrity, collagen distribution, architectural organization ganglia. specifically allows detailed fibers structures, revealing alterations density that correlate with dysautonomia. Methods: The cross-sectional was conducted at “Dr. Carol Davila” Central Military Emergency University Hospital, Bucharest, Romania, involving 70 participants diagnosed PD (Hoehn Yahr stages 2–4), including 35 dysautonomia without. We utilized samples patients without applying immunohistochemical markers for sympathetic neurons. Results: findings reveal pathological changes structure architecture. Immunohistochemical (neuropeptide Y, neurofilament heavy chain (NF-H), tyrosine hydroxylase) were employed characterize neurons, while provided high-resolution integrity extracellular matrix composition. Conclusions: These techniques present a promising tool early diagnosis assessment neurodegeneration patients. Moreover, these may represent critical bridge between histopathological clinical manifestations, underscoring their role enhancing our understanding dysfunction disease.
Language: Английский
Citations
0Journal of Controlled Release, Journal Year: 2024, Volume and Issue: 377, P. 716 - 734
Published: Dec. 3, 2024
Language: Английский
Citations
1